Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Melrose shares jump as H1 profit growth tops forecasts

(Sharecast News) - Melrose's share price jumped on Friday after the aerospace technology firm delivered a solid first-half report, with adjusted operating profits up by nearly a third. "We delivered a strong performance in the first half with a 29% improvement in profit and cash flow significantly stronger than last year despite the backdrop of supply chain and tariff disruptions," said chief executive Peter Dilnot.

Melrose reported an adjusted operating profit of £310m, up from £247m the year before, helped by a big improvement in operating margins to 18.0% from 14.2%. The consensus forecast was for a bottom-line figure closer to £299m.

The company said it made good margin progress in both its Engines and Structures division, as it was "successful in largely mitigating the direct impact of current tariffs".

Revenues were up 6% on last year on a like-for-like basis at £1.72bn, with 11% growth in Engines to £781m and 3% growth in Structures to £939m.

Looking ahead, the company kept its guidance on a constant-currency basis, though lowered forecasts slightly due to the strengthening of sterling against the US dollar.

Full-year revenues are now tipped to come in at between £3.43bn-3.58bn, down from £3.55bn-3.70bn previously, while the expected adjusted operating profit range has been cut to £620m-650m from £650m-690m.

"Our multi-year transformation programme will be completed by year end and the benefits are already reading through with more to come. We have a clear strategy underpinned by attractive aerospace and defence markets, differentiated technology and established positions on the world's leading civil and defence aircraft," Dilnot said.

The stock was up 7.5% at 550.8p by 0815 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.